Arcillas, Eduardo R.
HRN: 27-10-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/13/2025
07/20/2025
IV
500mg
Q8
Ascending Colon Mass
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines